Clinical Outcomes of Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Based on ANCA Type

OBJECTIVE: To evaluate whether the classification of ANCA-associated vasculitis (AAV) patients according to ANCA type (anti-proteinase 3 [PR3] or anti-myeloperoxidase [MPO] antibodies) predicts treatment response. METHODS: Treatment responses were assessed among patients enrolled in the Rituximab in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Rheum Dis
Autors principals: Unizony, Sebastian, Villarreal, Miguel, Miloslavsky, Eli M., Lu, Na, Merkel, Peter A., Spiera, Robert, Seo, Philip, Langford, Carol A., Hoffman, Gary S., Kallenberg, C.G. M., St. Clair, E. William, Ikle, David, Tchao, Nadia K., Ding, Linna, Brunetta, Paul, Choi, Hyon K., Monach, Paul A., Fervenza, Fernando, Stone, John H., Specks, Ulrich
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4908815/
https://ncbi.nlm.nih.gov/pubmed/26621483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-208073
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars